Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen-like compounds for ischemic neuroprotection.

James W Simpkins1, Shao-Hua Yang, Ran Liu

  • 1Department of Pharmacology & Neuroscience, 3500 Camp Bowie Blvd, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. jsimpkin@hsc.unt.edu

Stroke
|October 9, 2004
PubMed
Summary

New estrogen analogues show potent neuroprotection against stroke without typical estrogenic effects. These nonfeminizing compounds offer promising therapeutic potential for brain injury recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Non-Classical Neuroactive Steroid Exhibiting Potent, Efficacious GABA<sub>A</sub> Receptor Agonism and NMDA Receptor Inhibition.

bioRxiv : the preprint server for biology·2026
Same author

Review of the effect of atrazine on the HPG axes and steroidogenic pathways in males: relevance for testicular and prostate cancer.

Frontiers in toxicology·2026
Same author

Author Correction: 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.

Nature·2026
Same author

Structure-activity relationships of steroid and sterol neuromodulators on inflammatory markers in a murine microglial cell line.

The Journal of steroid biochemistry and molecular biology·2026
Same author

Live-Cell Imaging and Lipidomics of Low-Density Lipoprotein Containing Intrinsically Fluorescent Cholesteryl Esters.

Analytical chemistry·2026
Same author

The orientation of cholesterol's hydroxyl group affects its membrane dynamics and intracellular transport.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • Estrogen receptor (ER) signaling plays a role in neuroprotection.
  • Traditional estrogens have feminizing side effects limiting their therapeutic use.
  • Developing nonfeminizing ER modulators is crucial for neurological applications.

Purpose of the Study:

  • To synthesize and evaluate novel estrogen analogues.
  • To assess their binding affinity to ER-alpha and ER-beta.
  • To determine their neuroprotective efficacy in vitro and in vivo models of brain injury.

Main Methods:

  • Synthesis of a library of estrogen analogues, including estradiol enantiomers and A-ring substituted variants.
  • In vitro assays to measure binding to estrogen receptor-alpha and estrogen receptor-beta.

Related Experiment Videos

  • In vitro neuroprotection assays using cell models.
  • In vivo studies evaluating protection against cerebral ischemia/reperfusion injury.

    • Main Results:

    • Synthesized compounds demonstrated significantly reduced or no binding to ER-alpha and ER-beta.
    • These analogues exhibited enhanced neuroprotective activity in in vitro models.
    • The compounds proved potent in protecting brain tissue from cerebral ischemia/reperfusion injury.
    • The developed analogues are nonfeminizing.

    Conclusions:

    • Novel, nonfeminizing estrogen analogues possess significant neuroprotective properties.
    • These compounds are effective in preclinical models of stroke.
    • They represent promising therapeutic candidates for stroke neuroprotection, avoiding undesirable estrogenic side effects.